%0 Journal Article
%A J. J. Willeumier
%A N. M. A. van der Hoeven
%A L. Bollen
%A L. N. A. Willems
%A M. Fiocco
%A Y. M. van der Linden
%A P. D. S. Dijkstra
%T Epidermal growth factor receptor mutations should
be considered as a prognostic factor for survival of patients with
pathological fractures or painful bone metastases from non-small
cell lung cancer
%D 2017
%J The Bone & Joint Journal
%P 516-521
%V 99-B
%N 4
%R 10.1302/0301-620X.99B4.BJJ-2016-0872.R1
%U https://doi.org/10.1302/0301-620X.99B4.BJJ-2016-0872.R1
%K Bone metastases,Lung cancer,Pathological fracture,Survival,Prognosis,Epidermal growth factor receptor